Terms: = Sarcomas AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2 AND Prognosis
3 results:
1. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
[TBL] [Abstract] [Full Text] [Related]
2. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract] [Full Text] [Related]
3. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.
Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG
Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614
[TBL] [Abstract] [Full Text] [Related]
